Behavioral Sleep MedicinePub Date : 2026-03-01Epub Date: 2025-11-09DOI: 10.1080/15402002.2025.2586006
James M Puterflam, Janet M Y Cheung, Matthew Rahimi, Aaron Schokman, Jillian Eyles, Ronald R Grunstein, Paulo Ferreira, Christopher J Gordon
{"title":"Exploring the Interplay of Sleep Disturbance, Low Back Pain and Health Care Experiences: A Mixed Methods Study.","authors":"James M Puterflam, Janet M Y Cheung, Matthew Rahimi, Aaron Schokman, Jillian Eyles, Ronald R Grunstein, Paulo Ferreira, Christopher J Gordon","doi":"10.1080/15402002.2025.2586006","DOIUrl":"10.1080/15402002.2025.2586006","url":null,"abstract":"<p><strong>Objective: </strong>To explore the attitudes and experiences of people with chronic low back pain (LBP) on sleep, health care, and digital health.</p><p><strong>Method: </strong>Participants completed a survey about LBP, sleep, health care, and digital health. All data collected was self-reported by participants. Survey completers were invited for semi-structured interviews comprising open-ended questions exploring LBP and sleep interplay, health care experiences, and digital health preferences. Interviews were analyzed using a thematic framework approach.</p><p><strong>Results: </strong>Six-hundred and sixty-nine participants completed the survey. <i>n</i> = 501 female, mean age = 56.7 ± 14.4 years. Most participants (90%) reported LBP-related sleep disturbance. More than half (61%) were not satisfied with their current LBP-related health care Sixty-one percent of participants were willing to use a sleep-specific digital health intervention (DHI) if recommended by a health care professional. Interviews (<i>n</i> = 26) revealed three themes: (i) living with LBP and poor sleep, (ii) health-seeking behaviors, and (iii) implementing sleep and back pain DHIs. Participants were concerned with the legitimacy of non-health professional advice and preferred evidence-based DHIs.</p><p><strong>Conclusions: </strong>Sleep disturbance and health care dissatisfaction was highly prevalentin individuals with chronic LBP. Participants were willing to use evidence-based self-directed DHIs for LBP and sleep disturbance management but wanted clinical authority. These findings reveal opportunities for clinical implementation and intervention studies for individuals with chronic LBP and sleep disturbance.</p>","PeriodicalId":55393,"journal":{"name":"Behavioral Sleep Medicine","volume":" ","pages":"245-260"},"PeriodicalIF":2.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145483738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effect of Light Exposure Before Bedtime on Polysomnography and Sleep Quality: A Randomized Crossover Study.","authors":"Shu-Hua Lu, Hau Ting, Yun-Ping Lin, Jui-Fen Cheng, Hsiao-Ling Chuang, Wen-Chun Liao","doi":"10.1080/15402002.2025.2586789","DOIUrl":"10.1080/15402002.2025.2586789","url":null,"abstract":"<p><strong>Objectives: </strong>This study examined the effects of bedroom lighting with pre-bedtime activities two hours before bedtime on sleepiness and polysomnography (PSG) sleep in community-dwelling adults with poor sleep.</p><p><strong>Methods: </strong>A balanced crossover design was used with 24 healthy adults. Four lighting conditions under two activity situations (unrestricted (A1) and restricted (A2) electronic device use two hours before bedtime) were tested using adjustable LED lights: (E2: 3000K, 160 lux; E3: 5000K → 3000K, 160 → 30 lux; E4: 5000K, 160 lux) and compared to standard fluorescent lighting (E1: 5000K, 160 lux). The protocol lasted 8 nights (4 lightings × 2 activity conditions), with the whole night PSGmeasure, subjective sleep perception at wake-up, and sleepiness (Stanford Sleepiness Scale) measured hourly 2 hr before bedtime.</p><p><strong>Results: </strong>Results showed that sleep latency was 10.62 min longer when exposed to 5000k LED light than to 5000k FL. Exposure to other lower color temperature lights did not have a significant difference in sleepiness and PSGsleep. However, participants felt drowsier and had a shorter PSG sleep latency of 6.08 min when the use of electronic devices was not allowed.</p><p><strong>Conclusion: </strong>A 5000k LED light leads to longer sleep latency compared to a 5000k fluorescent light. Restriction of electronic device use before bedtime improves sleep onset in healthy adults. Managing ambient light exposure with lower color temperature LED light and reducing electronic device use 2 hr before bedtime may improve sleep quality in healthy adults.</p>","PeriodicalId":55393,"journal":{"name":"Behavioral Sleep Medicine","volume":" ","pages":"261-273"},"PeriodicalIF":2.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145534130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Can Addressing Autonomic Hyperarousal with Heart Rate Variability Biofeedback Enhance CBT-I Outcomes in Insomnia Disorder?","authors":"Yun-Kai Lin, Ya-Chuan Huang, Wuan-Chun Huang, Hsin-Chien Lee, I-Mei Lin, Chien-Ming Yang","doi":"10.1080/15402002.2025.2549554","DOIUrl":"10.1080/15402002.2025.2549554","url":null,"abstract":"<p><strong>Objectives: </strong>Insomnia often involves physiological hyperarousal, particularly autonomic dysregulation. Although Cognitive Behavioral Therapy for Insomnia (CBT-I) is effective, some patients do not achieve complete remission. This preliminary study evaluated whether combining CBT-I with heart rate variability (HRV) biofeedback could enhance treatment effects by improving autonomic regulation.</p><p><strong>Methods: </strong>Forty-four adults with insomnia were randomized to either a CBT-I group or a combined group that received HRV biofeedback (HRV-BF) and CBT-I (CBT-I+BF group). Both groups received seven weekly CBT-I sessions, with HRV-BF introduced in session four in the CBT-I+BF group. The primary outcome measure was the Insomnia Severity Index (ISI). Other outcome measures included the Pre-Sleep Arousal Scale (PSAS), sleep diaries, and HRV metrics. Assessments were conducted at baseline, post-treatment, and six-month follow-up. ISI and PSAS were also assessed at week 4 before the introduction of HRV-BF.</p><p><strong>Results: </strong>Both groups significantly improved in insomnia severity, pre-sleep arousal, and some sleep diary variables.The CBT-I+BF group showed unique and significant improvement in subjective total sleep time. While overall autonomic balance only showed a trend-level improvement in the CBT-I+BF group, sensitivity analyses on participants with more severe objective sleep disturbance suggested greater autonomic balance improvement for the CBT-I+BF group.</p><p><strong>Conclusions: </strong>Incorporating HRV-BF into CBT-I did not significantly enhance the benefits of CBT-I alone in this study. However, it offers additional advantages for individuals with more objective sleep disturbance, particularly in improving autonomic balance. Future research should identify optimal treatment intensity and explore the utility of HRV-BF in various insomnia sub-populations.</p>","PeriodicalId":55393,"journal":{"name":"Behavioral Sleep Medicine","volume":" ","pages":"40-57"},"PeriodicalIF":2.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144979671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Behavioral Sleep MedicinePub Date : 2026-01-01Epub Date: 2025-09-01DOI: 10.1080/15402002.2025.2549552
Jonna L Morris, Sanjay R Patel, Faith S Luyster
{"title":"Women's Experiences with Continuous Positive Airway Pressure for Treatment of Obstructive Sleep Apnea: A Qualitative study.","authors":"Jonna L Morris, Sanjay R Patel, Faith S Luyster","doi":"10.1080/15402002.2025.2549552","DOIUrl":"10.1080/15402002.2025.2549552","url":null,"abstract":"<p><strong>Introduction: </strong>Women are less adherent to continuous positive airway pressure (CPAP) treatment than men, but the reasons remain unclear. This study explored women's unique challenges, experiences, and support needs during CPAP initiation and adherence.</p><p><strong>Methods: </strong>Semi-structured interviews were conducted with 27 women who initiated CPAP for obstructive sleep apnea (OSA). Questions elicited detailed accounts of their challenges and perceptions of support. Responses were thematically analyzed by two independent reviewers to identify key conceptual categories.</p><p><strong>Results: </strong>Participants initiated CPAP a median of 2 years prior. Mean age was 51 ± 15 years; 29% were Black, 71% White. OSA severity included 40% mild, 21% moderate, 25% severe, and 14% unknown. Three themes emerged: women desired more practical and social support, social and personal factors acted as barriers and facilitators, and persistence and self-advocacy were key to success. Support from durable medical equipment companies, healthcare providers, friends, family, and social media was inconsistent. Women who faced frustration or significant barriers were less successful, while persistence and self-advocacy were critical for those who succeeded.</p><p><strong>Conclusion: </strong>Tailored support addressing women's personal circumstances and motivations may help overcome challenges during CPAP therapy initiation.</p>","PeriodicalId":55393,"journal":{"name":"Behavioral Sleep Medicine","volume":" ","pages":"29-39"},"PeriodicalIF":2.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144979712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Behavioral Sleep MedicinePub Date : 2026-01-01Epub Date: 2025-09-01DOI: 10.1080/15402002.2025.2552787
Sara Nishat, Tarushi Tanwar, Iram Iram, Shabnam Khan, Zubia Veqar
{"title":"Association Between Sleep and Depression in Patients with Fibromyalgia: A Systematic Review and Meta-Analysis of Observational Studies.","authors":"Sara Nishat, Tarushi Tanwar, Iram Iram, Shabnam Khan, Zubia Veqar","doi":"10.1080/15402002.2025.2552787","DOIUrl":"10.1080/15402002.2025.2552787","url":null,"abstract":"<p><strong>Objectives: </strong>Sleep and depression are known to be related in patients with fibromyalgia but the strength of this association is not well defined. Hence, this study aimed to investigate the association between subjective and objective sleep parameters with depression and to quantitatively summarize the results.</p><p><strong>Methods: </strong>Five English databases (PubMed, Web of Science, Scopus, Science Direct, Google Scholar) were systematically searched for studies published between January 2000 and March 2025. Statistical analyses were performed using MedCalc software.</p><p><strong>Results: </strong>28 studies matched the inclusion criteria, with a total sample size of 3,027 patients. Of these, 14 studies were included in the meta-analysis evaluating the association between PSQI and depression, which revealed a weakly positive association [pooled correlation coefficient <i>r</i> = 0.353 (95% CI: 0.264 to 0.435)]. In the meta-analysis of two PSG studies, TST showed a weak, non-significant inverse relationship with depression (<i>r</i> = -0.09). Other parameters WASO, sleep latency, sleep efficiency and % REM sleep also showed no significant associations. These PSG related findings remain non-conclusive and warrant further investigation.</p><p><strong>Conclusion: </strong>This meta-analysis highlights that there is a weak to moderate level of positive association between subjective sleep quality and depression in patients with fibromyalgia. High-quality PSG studies are needed to clarify the relationship of PSG parameters with depression.</p>","PeriodicalId":55393,"journal":{"name":"Behavioral Sleep Medicine","volume":" ","pages":"58-83"},"PeriodicalIF":2.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144979654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Behavioral Sleep MedicinePub Date : 2026-01-01Epub Date: 2025-09-26DOI: 10.1080/15402002.2025.2563555
Adam R Kinney, Lisa A Brenner, Rishi Deka, Xiang-Dong Yan, Jeri E Forster, Christi S Ulmer, Paul N Pfeiffer, Dara Ganoczy, Jennifer L Martin, Haylee Yepson, Nazanin H Bahraini
{"title":"Guideline-Concordant Cognitive Behavioral Therapy for Insomnia in the Veterans Health Administration Polytrauma/Traumatic Brain Injury System of Care.","authors":"Adam R Kinney, Lisa A Brenner, Rishi Deka, Xiang-Dong Yan, Jeri E Forster, Christi S Ulmer, Paul N Pfeiffer, Dara Ganoczy, Jennifer L Martin, Haylee Yepson, Nazanin H Bahraini","doi":"10.1080/15402002.2025.2563555","DOIUrl":"10.1080/15402002.2025.2563555","url":null,"abstract":"<p><strong>Objectives: </strong>Cognitive behavioral therapy for insomnia (CBT-I) is the recommended first-line treatment over medication. However, its use among Veterans in the Polytrauma/Traumatic Brain Injury System of Care (PSC) - a high-riskgroup for insomnia and medication complications - remains unclear. We describe CBT-I utilization in the PSC and identify predictors of receiving CBT-I.</p><p><strong>Method: </strong>We analyzed medical records of Veterans who initiated PSC services after 10/1/2019 and received either first-line CBT-I or sleep medications within one year. We modeled the likelihood of receiving first-line CBT-I vs. medications based on sociodemographic, clinical, spatial access (e.g. drive time), and facility-level factors (e.g. patient-reported access).</p><p><strong>Results: </strong>Veterans who received insomnia treatment after initiating PSC services (N = 18,293) were 85% male, 61% White, 21% Black or African American,14% Hispanic, and 8% age 65 or older. Only 11% received first-line CBT-I. Older Veterans; Native Hawaiian/Pacific Islander and Hispanic Veterans; those with bipolar disorder, depression, and alcohol use or other substance use disorders; and those with extended drive times were less likely to receive CBT-I. Findings were consistent in the sensitivity analysis.</p><p><strong>Conclusions: </strong>Veterans were approximately eight times more likely to receive medications than CBT-I. Implementation strategies that overcome barriers toguideline-concordant care in the PSC are needed.</p>","PeriodicalId":55393,"journal":{"name":"Behavioral Sleep Medicine","volume":" ","pages":"119-132"},"PeriodicalIF":2.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145152011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Behavioral Sleep MedicinePub Date : 2026-01-01Epub Date: 2025-08-22DOI: 10.1080/15402002.2025.2544975
Saebom Jeon, Eui Min Jeong, Young Rong Bang, Junseok Ahn, Soyoung Yoo, Jae Kyoung Kim, Seockhoon Chung
{"title":"Machine-Learning Validated Short Form of the Korean Version of the Sleep-Related Behaviors Questionnaire-10 Items: SRBQ-10.","authors":"Saebom Jeon, Eui Min Jeong, Young Rong Bang, Junseok Ahn, Soyoung Yoo, Jae Kyoung Kim, Seockhoon Chung","doi":"10.1080/15402002.2025.2544975","DOIUrl":"10.1080/15402002.2025.2544975","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to develop a short form of the Korean version of the Sleep-Related Behaviors Questionnaire (SRBQ) and assess its validity and psychometric properties.</p><p><strong>Method: </strong>We collected 300 responses from the EMBRAIN survey system and conducted exploratory and confirmatory factor analyses to group SRBQ items based on response similarity. The most representative item from each group was selected using eXtreme Gradient Boosting (XGBoost). The psychometric properties of the final 10 items were assessed using the Rasch model of item response theory (IRT).</p><p><strong>Results: </strong>Based on the selected 10 key items, we developed the SRBQ-10-a data-driven shortened version of the SRBQ, which demonstrated excellent performance (0.96) in predicting the SRBQ score, despite having only 10 items, which is one-third of the items in the original SRBQ-32. In addition to its reliability, the photometric properties of the SRBQ-10 were in the theoretically expected order, with no overlap or reversal of scale order, confirming the validity of the item scale.</p><p><strong>Conclusion: </strong>The SRBQ-10, a concise version of SRBQ, enables efficient screening of sleep-related behaviors in clinical settings. Our study framework combining classical test theory, XGBoost, and IRT can be applied to develop and validate shorter versions of other questionnaires.</p>","PeriodicalId":55393,"journal":{"name":"Behavioral Sleep Medicine","volume":" ","pages":"1-14"},"PeriodicalIF":2.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144979733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Behavioral Sleep MedicinePub Date : 2026-01-01Epub Date: 2025-09-02DOI: 10.1080/15402002.2025.2549550
Claudia Mc Brearty, Josée Savard
{"title":"Effects of Cognitive Therapy for Depression on Insomnia in Women with Metastatic Breast Cancer.","authors":"Claudia Mc Brearty, Josée Savard","doi":"10.1080/15402002.2025.2549550","DOIUrl":"10.1080/15402002.2025.2549550","url":null,"abstract":"<p><strong>Objective: </strong>This study assessed the effects of cognitive therapy (CT) for depression on insomnia in women with metastatic breast cancer.</p><p><strong>Methods: </strong>Thirty-four women with metastatic breast cancer and depressive symptoms were randomly assigned to CT for depression or a waitlist control group (WLC). Insomnia was measured using the Insomnia Severity Index (ISI) at pre-treatment (PRE) and posttreatment (POST), as well as 3 (FU3) and 6 (FU6) months later.</p><p><strong>Results: </strong>In the CT group, the proportion of women obtaining a clinically significant level of insomnia (ISI ≥8) decreased significantly from pre- to posttreatment (PRE = 80.0%; POST = 26.7%; <i>p</i> = .013). The mean ISI score differed significantly between groups at posttreatment/waiting (intervention = 5.5; control = 12.7; <i>p</i> = .048) and the ISI score decreased significantly from pre- to posttreatment (PRE = 11.5; POST = 5.5; <i>p</i> = .001). Additional analyses were performed pooling both groups together after WLC patients received CT. The proportion of patients with a clinical level of insomnia (PRE = 77.5%; POST = 28.3%; FU3 = 46.3%; FU6 = 21.0%; <i>p</i> < .0001), and the mean ISI score significantly decreased over time(PRE = 12.1; POST = 5.0; FU3 = 8.0; FU6 = 5.5; <i>p</i> < .0001).</p><p><strong>Conclusions: </strong>Although insomnia improved over time, 21.0% to 46.3% of women reported residual insomnia symptoms following CT for depression. Therefore, a concomitant treatment that directly targets insomnia should be provided to women with cooccurring depression and insomnia.</p>","PeriodicalId":55393,"journal":{"name":"Behavioral Sleep Medicine","volume":" ","pages":"15-28"},"PeriodicalIF":2.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144979726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Behavioral Sleep MedicinePub Date : 2026-01-01Epub Date: 2025-10-05DOI: 10.1080/15402002.2025.2569364
Hannah Scott, Than Thar Tun, Kelsey Bickley, Jenny Haycock, Claire Dunbar, Tessa Liebich, Gorica Micic, Nicole Lovato, Jeremy Mercer, Leon Lack, Alexander Sweetman
{"title":"Polysomnography and Diary-Measured Sleep Duration and Responsiveness to Cognitive Behavioral Therapy for Insomnia: A Chart-Review.","authors":"Hannah Scott, Than Thar Tun, Kelsey Bickley, Jenny Haycock, Claire Dunbar, Tessa Liebich, Gorica Micic, Nicole Lovato, Jeremy Mercer, Leon Lack, Alexander Sweetman","doi":"10.1080/15402002.2025.2569364","DOIUrl":"10.1080/15402002.2025.2569364","url":null,"abstract":"<p><strong>Objectives: </strong>Cognitive behavioral therapy for insomnia (CBT-I) is the recommended first-line treatment for insomnia. However, patients with objective short sleep duration may show a reduced response to CBT-I and require alternative or additional treatment.This study investigated the effect of objective and subjective short sleep duration before treatment on response to CBT-I in patients with chronic insomnia.</p><p><strong>Methods: </strong>We analyzed chart-review data from 446 patients with chronic insomnia (66.6% female, age <i>M</i> = 51.6 ± 15.6 years) treated with a 5-6 session CBT-I program in a sleep clinic. Short sleep duration was assessed from single-night polysomnography ( < 6 h:<i>n</i> = 254; ≥6 h:<i>n</i> = 178) and oneweek of sleep diaries ( < 6 h:<i>n</i> = 229; ≥6 h:<i>n</i> = 124). Mixed models tested for differences between sleep duration groups on changes in sleepdiary outcomes and daytime functioning questionnaires at post-treatment and three-month follow-up.</p><p><strong>Results: </strong>Short objective sleep duration predicted reduced improvements in daytime functioning (<i>p</i> = .019) and depression (<i>p</i> = .04), but no other outcomes. Short subjective sleep duration predicted greater improvement in all sleep diary outcomes (all <i>p</i> < .001). Results were consistent across sensitivity analyses.</p><p><strong>Conclusions: </strong>Objective and subjective sleep duration predicted some, mostly small, differences in treatment response to CBT-I in patients with chronic insomnia. That said, patients with short or normal sleep durations benefitted from CBT-I.</p>","PeriodicalId":55393,"journal":{"name":"Behavioral Sleep Medicine","volume":" ","pages":"133-146"},"PeriodicalIF":2.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145234221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}